Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Kelloff

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
EMBO Reports|April 6, 2005
Seeing into cells. The promise of in vivo molecular imaging in oncologyDaniel C Sullivan, Gary Kelloff
Medical Physics|January 7, 2003
RFA:CA-03-002: network for translational research: optical imagingLaurence P Clarke, Houston Baker, Gary Kelloff, et al.
Translational Oncology|December 4, 2009
Quantitative imaging for evaluation of response to cancer therapyLaurence P Clarke, Barbara S Croft, Robert Nordstrom, et al.
Translational Oncology|April 29, 2014
The Quantitative Imaging Network: NCI's Historical Perspective and Planned GoalsLaurence P Clarke, Robert J Nordstrom, Huiming Zhang, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in OncologyLaurent Dercle, Dana E Connors, Ying Tang, et al.
Science Translational Medicine|November 24, 2017
What evidence do we need for biomarker qualification?Chris Leptak, Joseph P Menetski, John A Wagner, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|December 17, 2013
Assessing the barriers to image-guided drug deliveryGregory M Lanza, Chrit Moonen, James R Baker, et al.
Critical Reviews in Oncology/Hematology|October 9, 2020
International liquid biopsy standardization alliance white paperDana Connors, Jeff Allen, J D Alvarez, et al.
Cancer Medicine|February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysisPallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Cytometry. Part B, Clinical Cytometry|May 6, 2017
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced InterpretersMichael Keeney, Brent L Wood, Benjamin D Hedley, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
EMBO Reports|April 6, 2005
Seeing into cells. The promise of in vivo molecular imaging in oncologyDaniel C Sullivan, Gary Kelloff
Medical Physics|January 7, 2003
RFA:CA-03-002: network for translational research: optical imagingLaurence P Clarke, Houston Baker, Gary Kelloff, et al.
Translational Oncology|December 4, 2009
Quantitative imaging for evaluation of response to cancer therapyLaurence P Clarke, Barbara S Croft, Robert Nordstrom, et al.
Translational Oncology|April 29, 2014
The Quantitative Imaging Network: NCI's Historical Perspective and Planned GoalsLaurence P Clarke, Robert J Nordstrom, Huiming Zhang, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in OncologyLaurent Dercle, Dana E Connors, Ying Tang, et al.
Science Translational Medicine|November 24, 2017
What evidence do we need for biomarker qualification?Chris Leptak, Joseph P Menetski, John A Wagner, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|December 17, 2013
Assessing the barriers to image-guided drug deliveryGregory M Lanza, Chrit Moonen, James R Baker, et al.
Critical Reviews in Oncology/Hematology|October 9, 2020
International liquid biopsy standardization alliance white paperDana Connors, Jeff Allen, J D Alvarez, et al.
Cancer Medicine|February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysisPallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Cytometry. Part B, Clinical Cytometry|May 6, 2017
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced InterpretersMichael Keeney, Brent L Wood, Benjamin D Hedley, et al.
Pageof 2